Anti-psychotic
medications, often known as tranquillizers or neuroleptics, are a class of
medication commonly used to treat schizophrenia and bipolar illness. They're
used to treat psychosis, which includes hallucinations, delusions, and paranoid
thoughts, among other things. Antipsychotic medications are successful in
treating psychosis in a short period of time. These medications inhibit the
action of dopamine, which is directly connected to psychotic symptoms, by
blocking dopamine receptors in the brain's dopaminergic pathways. Antipsychotic
use has increased as the prevalence of mental disorder has increased. According
to the National Alliance of Mental Illness, one in every five adults suffers
from mental illness, accounting for 18.5 percent of the overall population.
Long-term use of these medications, on the other hand, may cause adverse
effects such metabolic syndrome and involuntary movement disorder, leading to
an increase in mortality in the older population with dementia.
Increase in prevalence of mental
disorders to fuel the growth of anti-psychotic drugs market
Schizophrenia
is the leading cause of psychosis worldwide, and patients with the illness are
more likely to develop physical and mental illnesses. In 2016, approximately 21
million people worldwide were diagnosed with schizophrenia, according to the
World Health Organization (WHO). According to the WHO, one out of every two
patients with schizophrenia does not receive adequate treatment. This is an
opportunity for industry participants in the worldwide anti-psychotic
drugs market to find cost-effective treatments for this disease.
Furthermore, according to the National Alliance of Medical Illness,
approximately 1.1 percent of adults in the United States suffer from schizophrenia,
while 2.6 percent suffer from bipolar disorder. In a given year, one in every
five individuals in the United States, or 43.8 million people, or 18.5 percent
of the overall population, suffers from some form of mental illness. The market
for antipsychotic medications is growing due to the high frequency and
increasing incidence of neurological illnesses.
Comments
Post a Comment